|
Real-time Estimate
Cboe BZX
11:44:42 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 34.94 USD | +0.33% |
|
+0.52% | +13.38% |
| 09-24 | AbbVie Says Health Canada Issues Notice of Compliance for EPKINLY in Follicular Lymphoma | MT |
| 09-24 | Hansa Biopharma brings in two new board members | FW |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Genmab A/S(GMAB)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Genmab A/S(GMAB)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Genmab A/S(GMAB)
EBIT
Dividend / Share (DPS)
Data source:
Genmab A/S(GMAB)
Cash or Net Debt
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
- Consensus Genmab A/S
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
